CN1273122A - Synthetic orall liquid of red sage root - Google Patents

Synthetic orall liquid of red sage root Download PDF

Info

Publication number
CN1273122A
CN1273122A CN99112197A CN99112197A CN1273122A CN 1273122 A CN1273122 A CN 1273122A CN 99112197 A CN99112197 A CN 99112197A CN 99112197 A CN99112197 A CN 99112197A CN 1273122 A CN1273122 A CN 1273122A
Authority
CN
China
Prior art keywords
parts
radix
synthetic
prescription
red sage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN99112197A
Other languages
Chinese (zh)
Other versions
CN1098701C (en
Inventor
吴景芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99112197A priority Critical patent/CN1098701C/en
Publication of CN1273122A publication Critical patent/CN1273122A/en
Application granted granted Critical
Publication of CN1098701C publication Critical patent/CN1098701C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicinal oral liquid for treating cardioavscular and cerebrovascular diseases is prepared from three prescriptions A, B and C. Said prescription A includes red sage root, astragalus root, ginseng and Chuan-xiong rhizome. Said prescription B is honey. Said prescription C includes musk and bovine bezour. Its advantages are high curative effect, low dosage, quickly taking its effect and no by-effect.

Description

Synthetic orall liquid of red sage root
The present invention relates to a kind of Chinese medicine, is a kind of Chinese medicine tincture for the treatment of cardiovascular and cerebrovascular disease specifically.
Cardiovascular and cerebrovascular disease belongs to old common disease, and is as hypertension, coronary heart disease, arteriosclerosis, hemiplegia etc., very big to human health damage, there is not highly effective Drug therapy for this class disease at present, can only relief of symptoms, the need that have are taken for a long time to keep effect, can not effect a radical cure.In addition, Chinese patent medicines of some treatment cardiovascular and cerebrovascular diseases mostly are pill or capsule, make trouble, and oral dose is big, the patient with after easily cause gastrointestinal upset, absorb slowly, produce effects is slow, will catch in the while use and touch medicine, not really health.
The purpose of this invention is to provide the synthetic tincture of a kind of Chinese medicine, the various disease conditions that causes for cardiovascular and cerebrovascular disease has remarkable result, reduces oral dose, and produce effects is fast, has no side effect.
The present invention processs synthetic tincture by A, B, C three folk prescription branches,
Wherein the weight proportion of each Chinese medicinal components of A side is: 250~300 parts of Radix Salviae Miltiorrhizaes, 250~300 parts of the Radixs Astragali, 250~300 parts of Radix Ginsengs, 200~300 parts of Rhizoma Chuanxiongs, 200~300 parts in Radix Rehmanniae Preparata, 200~250 parts of Radix Angelicae Sinensis, 200~250 parts of Radix Saposhnikoviaes, 150~200 parts of Radix Puerariaes, 60~100 parts at antelope angle, 150~200 parts of Radix Notoginseng, 200~250 parts of Radix Achyranthis Bidentataes, 250~300 parts of Bi , 150~200 parts of Resina sophorae, 200~250 parts on Flos Carthami, 50~100 parts of Herba Schizonepetae, 50~100 parts of Herba Menthaes, 200~250 parts of Cortex Magnoliae Officinalis, 200~250 parts of Fructus Aurantii Immaturuss, 200~250 parts of Fructus Crataegis, 60~100 parts of Hirudos, 250~300 parts in Radix Glycyrrhizae;
B side is 1000 parts of high-quality Mel;
C side is 10~15 parts in Moschus, 20~30 parts of Calculus Boviss.
The present invention's prescription is on the basis of tonification, associate with suppressing the hyperactive liver to relieve the wind syndrome, blood circulation promoting and blood stasis dispelling, blood pressure lowering heart tonifying, the medication combined of heat-clearing and toxic substances removing, branch is processed synthetic, the vascular fragility of reduction and permeability are arranged, it is thick to alleviate the sticking blood of erythrocyte aggregation and anticoagulant, reduction blood, improves the microcirculation of vitals such as the heart, brain, kidney, lung, regulates tissue repair and regeneration, strengthen the metabolism of human body, strengthen the effect of myocardial contraction and circulation blood vessels.The various diseases that are mainly used in cardiovascular and cerebrovascular disease and cause, as hypertension, coronary heart disease, angina pectoris, sensation of oppression over the chest with shortness of breath, headache and dizzy, cerebral infarction, hemiplegia, numbness of hands and feet, spoken unclear etc., viral cardiomyopathy, pulmonary heart disease, rheumatism also there is certain curative effect.Adopt three folk prescription branches to process simultaneously and synthesize tincture, the suitable expansion content of medicine of respectively distinguishing the flavor of improves the concentration of finished product, makes oral dose little, and produce effects is rapid, and patient's medication no pain has no side effect, and uses also much cleaner.Existing nearly hundred cardiovascular and cerebrovascular vessel patients used this side, obvious effective rate 100%, and untoward reaction did not appear in cure rate about 85%.
Be described in detail the present invention below in conjunction with embodiment.
A side is totally 21 flavor medicines, get Radix Salviae Miltiorrhizae 250g, Radix Astragali 250g, Radix Ginseng 250g, Rhizoma Chuanxiong 200g, Radix Rehmanniae Preparata 200g, Radix Angelicae Sinensis 200g, Radix Saposhnikoviae 200g, Radix Puerariae 150g, antelope angle 60g, Radix Notoginseng 150g, Radix Achyranthis Bidentatae 200g, Bi  250g, Resina sophorae 150g, Flos Carthami 200g, Herba Schizonepetae 50g, Herba Menthae 50g, Cortex Magnoliae Officinalis 200g, Fructus Aurantii Immaturus 200g, Fructus Crataegi 200g, Hirudo 60g, Radix Glycyrrhizae 250g, above raw material ground be smalls, process with the 10kg decocting, the extracting juice post precipitation that removes slag, clear juice is put into container, and clean meter is no more than 5kg; B side is high-quality Mel 1000g, fries in shallow oil into iron pan and puts into the container cooling after dark brown; Moschus 10g, Calculus Bovis 20g get in C side, put into glass container, after the dissolving of 300g warm water, seal half an hour.Synthesize after A, B, C three parts prepare, be about to tripartite medicinal liquid and put into container and mix well sealing and get final product.Last available 100 milliliters Clear glass bottles and jars packing should be adorned 55~60 bottles.The finished product oral liquid is Umber, sticking shape, and bitter in the mouth is sweet.
Usage and consumption: oral one time 5~10 milliliters, day clothes secondary or follow the doctor's advice.With preceding medicine is shaken up.Treat that sb.'s illness took a favorable turn (10~20 days), use instead once a day, take continuously.Apoplexy sequela, anemia of pregnant woman's forbidding.Storage and preservation: storage life 1 year is deposited at ventilation, shady and cool place.

Claims (1)

1, a kind of Chinese medicine preparation Radix Salviae Miltiorrhizae oral liquid for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is to process synthetic tincture by A, B, C three folk prescription branches,
Wherein the weight proportion of each Chinese medicinal components of A side is: 250~300 parts of Radix Salviae Miltiorrhizaes, 250~300 parts of the Radixs Astragali, 250~300 parts of Radix Ginsengs, 200~300 parts of Rhizoma Chuanxiongs, 200~300 parts in Radix Rehmanniae Preparata, 200~250 parts of Radix Angelicae Sinensis, 200~250 parts of Radix Saposhnikoviaes, 150~200 parts of Radix Puerariaes, 60~100 parts at antelope angle, 150~200 parts of Radix Notoginseng, 200~250 parts of Radix Achyranthis Bidentataes, 250~300 parts of Bi , 150~200 parts of Resina sophorae, 200~250 parts on Flos Carthami, 50~100 parts of Herba Schizonepetae, 50~100 parts of Herba Menthaes, 200~250 parts of Cortex Magnoliae Officinalis, 200~250 parts of Fructus Aurantii Immaturuss, 200~250 parts of Fructus Crataegis, 60~100 parts of Hirudos, 250~300 parts in Radix Glycyrrhizae;
B side is 1000 parts of high-quality Mel;
C side is 10~15 parts in Moschus, 20~30 parts of Calculus Boviss.
CN99112197A 1999-05-08 1999-05-08 Synthetic orall liquid of red sage root Expired - Fee Related CN1098701C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99112197A CN1098701C (en) 1999-05-08 1999-05-08 Synthetic orall liquid of red sage root

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99112197A CN1098701C (en) 1999-05-08 1999-05-08 Synthetic orall liquid of red sage root

Publications (2)

Publication Number Publication Date
CN1273122A true CN1273122A (en) 2000-11-15
CN1098701C CN1098701C (en) 2003-01-15

Family

ID=5275526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99112197A Expired - Fee Related CN1098701C (en) 1999-05-08 1999-05-08 Synthetic orall liquid of red sage root

Country Status (1)

Country Link
CN (1) CN1098701C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1296078C (en) * 2005-06-09 2007-01-24 邱电相 Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease
CN1907320B (en) * 2005-08-04 2010-07-07 吉林康乃尔药业有限公司 Traditional Chinese medicine compound, processes for preparing traditional Chinese medicine therefrom and use thereof
CN103202895A (en) * 2013-04-25 2013-07-17 赵彦强 Spray for treating heart disease
CN105125996A (en) * 2015-10-05 2015-12-09 南京多宝生物科技有限公司 Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1142952A (en) * 1994-12-17 1997-02-19 李高寅 Glossy ganoderma oral liquor and its preparing method
CN1110176A (en) * 1995-01-19 1995-10-18 余练康 Oral drug for curing diabetes and complicated angiocardiopathy
CN1200278A (en) * 1997-05-26 1998-12-02 万福源 Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1296078C (en) * 2005-06-09 2007-01-24 邱电相 Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease
CN1907320B (en) * 2005-08-04 2010-07-07 吉林康乃尔药业有限公司 Traditional Chinese medicine compound, processes for preparing traditional Chinese medicine therefrom and use thereof
CN103202895A (en) * 2013-04-25 2013-07-17 赵彦强 Spray for treating heart disease
CN105125996A (en) * 2015-10-05 2015-12-09 南京多宝生物科技有限公司 Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease

Also Published As

Publication number Publication date
CN1098701C (en) 2003-01-15

Similar Documents

Publication Publication Date Title
CN102078402A (en) Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia
CN102406911B (en) Chinese medicine preparation for treating coronary heart disease
CN103330805A (en) Traditional Chinese medicine composition for treating menorrhagia
CN101485803B (en) Chinese medicinal composition for treating menoxenia and dysmenorrhea
CN101095768B (en) Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
CN102671178B (en) Preparation method of Chinese medicinal composition for treating nephrotic syndrome and uremia and application thereof
CN103041200B (en) Traditional Chinese medicine composition for treating cerebral hemorrhage
CN104706999A (en) Traditional Chinese medicinal composition for regulating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicinal composition
CN1098701C (en) Synthetic orall liquid of red sage root
CN102657795A (en) Traditional Chinese medicine preparation for promoting postoperative incision healing
CN1053189A (en) The preparation method of " promoting blood circulation and restoring paralysis pills "
CN103182008A (en) Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure
CN105031244A (en) Healthcare wine and preparation method thereof
CN104606561A (en) Traditional Chinese medicinal composition for treating spontaneous perspiration
CN104547747A (en) Fast-acting medicinal liquor for treating wind-cold-dampness arthralgia and application thereof
CN1285378C (en) Nourishing wine for regulating human body balance function
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN1134839A (en) Medicated wine for expelling wind
CN101810771A (en) Chinese medicinal preparation for curing coronary heart disease and angina pectoris
CN1059336C (en) Oral liquor for curing senile dementia and constipation
CN104888133A (en) Traditional Chinese medicine composition for treatment of coronary heart disease
CN104547369A (en) Oral medicine for treating blepharospasm and preparation method thereof
CN103028076A (en) Traditional Chinese medicine composition for treating liver cirrhosis
CN102641420B (en) Pharmaceutical composition for treating coronary heart disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030115